Study of Psychopathological Characteristics of Patient Smoking in Thoracic Oncology

NCT01955057 | Completed

• 1 other identifier: 5579
• Study Type: observational
• Target: 50
• Locations: 1 country
• Sites: 1

Brief Summary

Persistent smoking after lung cancer has been the subject of medical, therapeutic and epidemiological publications for twenty years of research. Continued persistent smoking is all the more a problem for oncologists as there is evidence that smoking cessation, with lung cancer, gives therapeutic benefit. Quitting smoking can improve the response to treatments (chemotherapy, radiotherapy, surgery), quality of life and overall survival. However many patients refuse adhesion to tobacco cessation. Daily practice leads us to the hypothesis that adhesion differences aren't related to the denial of medical information, nor to resignation or to nicotine dependence. Patients who continue smoking seem to face a form of impossibility to wean. Cigarette seems to be felt as a part of their body in their narration and description of their body image.

Conditions

Smoking Cessation and Lung Cancer

Outcome Measures

Primary Outcomes (2)

• Composite indicator variable indicating the presence or absence of disturbance in one or more of the parameters evaluated: object relations, body, subject's choice.

  The results will be obtained: * From the results of each test, each has indeed a standardized rating scale * By analysing the content of the speech of the patient previously noted during the various interviews The investigator will classify each subject in "disturbance" or not for each of the three parameters. The presence of at least one disturbance gives the "yes" value in the indicator variable, "no" in the absence of the three disturbances.

  2 months after inclusion

• Composite indicator variable indicating the presence or absence of disturbance in one or more of the parameters evaluated: object relations, body, subject's choice.

  The results will be obtained: * From the results of each test, each has indeed a standardized rating scale * By analysing the content of the speech of the patient previously noted during the various interviews The investigator will classify each subject in "disturbance" or not for each of the three parameters. The presence of at least one disturbance gives the "yes" value in the indicator variable, "no" in the absence of the three disturbances.

  4 months after inclusion

Study Arms (1)

Smokers with lung cancer

Behavioral: Research interviews; Behavioral: Tests (Fagerström, Q-MAT, H.A.D.S, SCL 90-R); Behavioral: Projective methods (Thematic apperception Test, Rorschach); Behavioral: Carbon monoxide test

Interventions

Research interviews BEHAVIORAL

Smokers with lung cancer

Tests (Fagerström, Q-MAT, H.A.D.S, SCL 90-R) BEHAVIORAL

Smokers with lung cancer

Projective methods (Thematic apperception Test, Rorschach) BEHAVIORAL

Smokers with lung cancer

Carbon monoxide test BEHAVIORAL

Smokers with lung cancer

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

Patients will be recruited in the pneumology ward of Strasbourg University Hospital, precisely in hospitalization units involved in cancer care (Units 1404,1403,1202,2099)

You may qualify if:

• Men and women aged 18 years or older
• Patient affiliated to a social security system
• Patient who has signed and dated informed consent, written before all procedures related to the study
• Patient who has received the results of the previous mandatory medical examination
• Patient who has been diagnosed with lung cancer, regardless of the histological type of the cancer
• Patient who is being treated for lung cancer (surgery, chemotherapy, radiotherapy) and not another form of cancer
• Tobacco consumer's only by smoke inhalation
• Tobacco consumer's or tobacco associated with cannabis

You may not qualify if:

• Major patient under guardianship or curatorship or maintenance of justice
• Patient deprived of his liberty or in an emergency situation
• Patient with a Performance Statut(OMS) higher than 2 and/or with a psychiatric disorder like " schizophrenia and other psychotic disorders " (DSM IV)
• A palliative care patient
• Patient who began smoking during his diagnostic examination or after the diagnosis of cancer
• A pregnant or breastfeeding woman

Sponsors & Collaborators

• University Hospital, Strasbourg, France: lead

Study Sites (1)

Nouvel Hôpital Civil, Service de pneumologie, Unité de cancérologie thoracique, Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location

MeSH Terms

Conditions

Smoking Cessation; Lung Neoplasms

Interventions

Thematic Apperception Test

Condition Hierarchy (Ancestors)

Health Behavior; Behavior; Respiratory Tract Neoplasms; Thoracic Neoplasms; Neoplasms by Site; Neoplasms; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Projective Techniques; Personality Tests; Psychological Tests; Behavioral Disciplines and Activities

Study Officials

• Jonathan GRAFFI

  Hôpitaux Universitaires de Strasbourg

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 20, 2013
• First Posted: October 7, 2013
• Study Start: December 1, 2013
• Primary Completion: June 1, 2016
• Study Completion: June 1, 2016
• Last Updated: June 9, 2016

Record last verified: 2016-06

Locations

FR (1)